Skip to main content

Table 3 Results (FDR correct P-values) of Metabolite Set Enrichment Analysis using MetaboAnalyst showing consistent changes among lipids

From: Oral administration of TiO2 nanoparticles during early life impacts cardiac and neurobehavioral performance and metabolite profile in an age- and sex-related manner

Lipid subclass

PND 2–5

PND 7–10

PND 17–20

Male

Female

Male

Female

Male

Female

1-Alkyl,2-acylglycerophosphocholines

0.00119

2.02 × 10−37

1.82 × 10−15

6.29 × 10−9

0.0014

4.21 × 10−4

Acylcarnitines

1

0.00779

8.72 × 10−4

Ceramide phosphocholines

7.41 × 10−4

8.90 × 10−4

Diacylglycerophosphocholines

6.88 × 10−60

8.84 × 10−142

6.13 × 10−72

2.74 × 10−5

6.38 × 10−71

4.81 × 10−34

Fatty acid esters

0.0306

Fatty acylcarnitines

0.0445

0.00391

1.07 × 10−9

2.52 × 10−14

2.77 × 10−4

Glycerophosphocholines

1.59 × 10−4

0.00779

0.0495

Glycerophospholipids

3.92 × 10−5

0.00779

0.0460

Lysophosphatidylcholines

0.0420

5.75 × 10−5

0.0126

0.0373

0.0171

Monoacylglycerophosphocholines

0.0439

0.0162

Phosphosphingolipids

1.13 × 10−5

7.19 × 10−5

1.30 × 10−10

0.00354

0.00155

Short-chain acylcarnitines

6.11 × 10−8

1.30 × 10−9

2.87 × 10−9

  1. 1FDR corrected P-value > 0.05 was marked by “–”